Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study

Authors :: Molina, Jean-Michel
Ghosn, Jade
Assoumou, Lambert
Delaugerre, Constance
Algarte-Genin, Michèle
Pialoux, Gilles
Katlama, Christine
Slama, Laurence
Liegeon, Geoffroy
Beniguel, Lydie
Ohayon, Michel
Mouhim, Hanane
Goldwirt, Lauriane
Spire, Bruno
Loze, Bénédicte
Surgers, Laure
Pavie, Juliette
Lourenco, Jérémy
Ben-Mechlia, Mohamed
Le Mestre, Soizic
Rojas-Castro, Daniela
Costagliola, Dominique
Source :: The Lancet HIV; August 2022, Vol. 9 Issue: 8 pe554-e562, 9p
Publication Year :: 2022
Abstract: There are few data available regarding the use of on-demand pre-exposure prophylaxis (PrEP) for HIV prevention. We aimed to assess PrEP effectiveness, adherence, and safety in adults using daily or on-demand PrEP.

Full Text Access

Tools